LONDON GlaxoSmithKline (GSK) has kicked off the sale of some consumer health brands as it seeks to raise about £1 billion before pressing ahead with a spinoff of its consumer healthcare business, sources told Reuters.
LONDON Doing things one at a time in drug development is not a luxury that GlaxoSmithKline can afford any longer, the head of pharmaceuticals at Britain's largest drugmaker told Reuters.
Frankfurt Nach Manager-Schelte, Kursverfall und einer Klagewelle in den USA versucht Bayer, wieder in die Offensive zu kommen:
FRANKFURT Germany's Bayer sought to repair its reputation on Friday after damage caused by U.S. litigation over claims its glyphosate pesticide causes cancer, saying it would invest 5 billion euros ($5.6 billion) in weedkiller research.
British drugmaker GSK said it has struck a research deal with the early pioneers of a prominent gene-editing technology at the University of California, in a boost to its prospects for developing new drugs.
FRANKFURT German drugmaker Fresenius warned that stricter production norms being considered by Europe's drug regulator could compound shortages of a life-saving antibiotic that is used by about 25 million patients globally each year.
FRANKFURT Bayer announced a collaboration deal with Roche's Foundation Medicine Inc. to develop a test for sequencing tumour genomes to identify patients who can benefit from Bayer's cancer drug hopeful Vitrakvi.
Frankfurt Bayer shares fell by as much as 5 percent on Tuesday after a California couple were awarded more than $2 billion (1.54 billion pounds) in the largest U.S. jury penalty over allegations its Roundup weed killer causes cancer. | Video